PHACE syndrome
 | This article may require copy editing for numerous problems with MOS:MED. (May 2022) |
| PHACE Syndrome | |
|---|---|
| Other names | Pascual-Castroviejo type II syndrome, P-CIIS, Pascual-Castroviejo syndrome type 2[1] |
| Specialty | Medical genetics  |
PHACE syndrome is a cutaneous condition characterized by multiple congenital abnormalities.[2][3] The mnemonic PHACE stands for Posterior fossa brain malformations, Hemangioma, Arterial lesions, Cardiac abnormalities, and Eye abnormalities.[4]
PHACE syndrome may affect infants with large plaque-type facial hemangiomas.[5] Children who present this dermatologic manifestation should receive careful ophthalmologic, cardiac, and neurologic assessment.
According to one study of infants with large hemangiomas, one-third have extracutaneous manifestations consistent with the diagnosis of PHACE syndrome. The most common are cerebrovascular and cardiovascular anomalies.[6]
Signs and symptoms
Hemangiomas associated with PHACE syndrome are generally small or not visible at birth, but often proliferate during the first days or weeks of life, gradually becoming easier to see. Hemangiomas linked with PHACE syndrome, tend to cover a large area of the face, head, or neck, either as one lesion or as many individual lesions.
Patients with PHACE syndrome may also experience symptoms such as:
- Anomalies of the aortic arch.
- Narrowing, abnormal growth, or absence of a major cerebral artery.
- Presence of the trigeminal artery, an important artery that supplies the brain with nutrients during fetal development, as well as others after birth.
- Abnormalities of the cerebellum.
- Blood clots in the blood vessels around the heart and brain.
- Abnormal structure of the back of the eye.
- Abnormal sternum.
- Gaps in the wall between the left and right ventricles of the heart.
- Anomalies of the pituitary and thyroid glands.[7]
Complications
As it grows, the hemangioma can break down the skin, distort facial features, or get in the way of other vital functions, such as breathing, vision, and hearing. Further complications will depend on what other structures are involved. These could include developmental delay, seizures, headaches, and abnormal muscle tone, if the brain is affected.
Cause
The cause of PHACE syndrome is currently unknown. Researchers believe that it is caused by a postzygotic somatic mosaic mutation, or a mutation that can occur on any autosomal chromosome. Research is complicated due to the mosaic nature of the disease.[8] The disorder may be caused by genetic or environmental factors, or a combination of the two.[9]
Diagnosis
Since the initial sign of PHACE syndrome is usually a large facial hemangioma, infants born with this condition should be further evaluated to diagnose or rule out PHACE syndrome through a series of radiologic tests such as magnetic resonance images (MRI) or a magnetic resonance angiograms (MRA) of the head, neck, and chest. Following the imaging tests, the physician should perform an echocardiogram on the infant to observe any abnormalities. If abnormalities are detected on these scans, the infant may have PHACE syndrome.[10]
Treatment
Due to the disorder's rarity, there are no standardized treatment protocols or guidelines and no medical treatment trials for affected individuals as of 2022. Various treatments have been reported in the medical literature as part of single case reports or small series of patients.[11]
Physicians treat specific complications and effects of the disorder in order to improve the lives of patients. Treatment usually involves collaboration between many medical professionals. These medical professionals include, but are not limited to, dermatologists; ophthalmologists; cardiologists; endocrinologists; neurologists and or neurosurgeons; otolaryngologists; dentists; speech pathologists; psychiatrists; and many others.[12]
Management
PHACE syndrome needs to be managed by a multidisciplinary team of experts. Additional specialties such as cardiology, ophthalmology, neurology, and neurosurgery may need to be involved. The experts pay close attention to how these children develop throughout school-age.[13][14]
Since the establishment of the PHACE syndrome community non-profit in 2013, it has been raising awareness about the condition, supporting patients and families of those with the disease, and raising money for research into causes and treatment.
History
PHACE syndrome is the uncommon association between large infantile hemangiomas, usually of the face, and birth defects of the brain, heart, eyes, skin and/or arteries. It is an acronym that stands for the medical names of the parts of the body it often impacts:
- Posterior fossa abnormalities and other structural brain abnormalities.
- Hemangioma(s) of the cervical facial region.
- Arterial cerebrovascular anomalies.
- Cardiac defects, aortic coarctation and other aortic abnormalities.
- Eye anomalies.
Sometimes an "S" is added to PHACE making the acronym PHACES; with the "S" standing for "Sternal defects" and/or "Supraumbilical raphe."
In 1993, a correlation between large facial hemangiomas and brain defects among 9 subjects was reported.[15] 3 years later, a larger case study was published showing a wider spectrum of grouped malformations.[16] The association of anomalies and the PHACES acronym was first coined by Dr. Vail Reese and Dr. Ilona Frieden in 1996, making it a newly described syndrome. A diagnosis is generally made from the physical examination, along with imaging of the head and chest, and an eye examination. PHACE is most commonly diagnosed among female infants. Long-term quality of life varies.
The hemangioma growth phase can last anywhere from 6 to 18 months. Then involution, or healing, of the hemangioma begins. Laser and other surgeries can usually make a substantial positive impact on appearance. Long after the hemangioma recedes, any damage it or the other defects caused may remain. Migraines are common, as are developmental delays.
See also
References
- ^ "PHACE syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 27 April 2019.
- ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
- ^ Hartemink, David A.; Chiu, Yvonne E.; Drolet, Beth A.; Kerschner, Joseph E. (February 2009). "PHACES syndrome: a review". International Journal of Pediatric Otorhinolaryngology. 73 (2): 181–7. doi:10.1016/j.ijporl.2008.10.017. PMID 19101041.
- ^ "PHACE Syndrome". Cincinnati Children's Hospital Medical Center. Retrieved 2018-10-25.
- ^ Metry, DW; Dowd, CF; Barkovich, AJ; Frieden, IJ (2001). "The many faces of PHACE syndrome". The Journal of Pediatrics. 139 (1): 117–23. doi:10.1067/mpd.2001.114880. PMID 11445804.
- ^ Haggstrom, AN; Garzon, MC; Baselga, E; Chamlin, SL; Frieden, IJ; Holland, K; Maguiness, S; Mancini, AJ; McCuaig, C; Metry, DW; Morel, K; Powell, J; Perkins, SM; Siegel, D; Drolet, BA (2010). "Risk for PHACE syndrome in infants with large facial hemangiomas". Pediatrics. 126 (2): e418–26. doi:10.1542/peds.2009-3166. PMID 20643720. S2CID 25928589.
- ^ "PHACE Symptoms & Causes". Boston Children's Hospital. Retrieved 2018-10-24.
- ^ Thorpe, Jeremy; Osei-Owusa, Ikeoluwa; Erlanger Avigdor, Bracha; Tupler, Rossella; Pevsner, Jonathan (2022-09-11). "Mosaicism in Human Health and Disease". Annual Review of Genetics. 54: 487–510. doi:10.1146/annurev-genet-041720-093403. PMC 8483770. PMID 32916079.
- ^ "PHACE Syndrome - NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). Retrieved 2018-10-25.
- ^ "PHACE syndrome". Children's Hospital of Wisconsin. Retrieved 2018-10-25.
- ^ Lanes, Marsha. "PHACE Syndrome". NORD (National Organization for Rare Disorders). Retrieved 2022-07-11.
- ^ "PHACE Syndrome - NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). Retrieved 2018-10-25.
- ^ "PHACE Syndrome Community".
- ^ Drolet, Beth. "PHACE Syndrome handbook". Children's Hospital of Wisconsin. Archived from the original on 16 July 2016. Retrieved 6 June 2022.
- ^ Reese, V; Frieden, IJ; Paller, AS; Esterly, NB; Ferriero, D; Levy, ML; Gellis, SE; Siegfried, EC (March 26, 1993). "Association of facial hemangioma with Dandy-Walker and other posterior fossa malformations". Journal of Pediatrics. 122 (3): 379–384. doi:10.1016/s0022-3476(05)83420-1. PMID 8441091. Retrieved 10 October 2016.
- ^ Frieden, IL; Reese, V; Cohen, D (Mar 1996). "PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities". Archives of Dermatology. 132 (3): 307–311. doi:10.1001/archderm.132.3.307. PMID 8607636.